##plugins.themes.academic_pro.article.main##

Abstract

This  work  examined  the  diagnostic  role  of  biomarkers -APRI, alpha-fetoprotein–AFP  and gammaglutamine transpeptidase–GGTP before and after antiviral therapy in patients with different degrees of liver fibrosis. At the same time, there was a decrease in these indicators after treatment, which indicates a reverse development of liver fibrosis after specific therapy.During therapy, a significant decrease in APRI from 0.67 to 0.33 (p<0.05), AFP from 4.82 to 1.77 (p<0.01) and GGTP from 42.4 to 26.8 was established (p<0.05).  Thus,  APRI,  AFP  and  GGTP  indicators  can  be  used  as  dynamic  markers  for  assessing  the antifibroticeffect of etiotropic therapy for hepatitis C

Keywords

hepatitis C virus fibrosis APRI

##plugins.themes.academic_pro.article.details##

How to Cite
Bayjanov A.K, Nasirova Х.P, Khikmatullaeva A.S, Abdukadirova M.A, Yarmukhamedova N.A, Raximova V.Sh, Brigida K.S., Ibadullaeva N.S, Mirrakhimova N.M, Каn N, & Matyakubova Feruza Egamovna. (2024). Study Of Indirect Fibromarkers inIdentifying theDegree ofLiver Fibrosis During Antiviral Therapy Of Patients With Hepatitis HCV Etiology. Texas Journal of Medical Science, 37, 7–12. https://doi.org/10.62480/tjms.2024.vol37.pp7-12

References

Read More